These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1942134

  • 1. Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
    Ueda T, Yasumasu T, Uozumi J.
    J Toxicol Sci; 1991 Aug; 16(3):101-9. PubMed ID: 1942134
    [Abstract] [Full Text] [Related]

  • 2. [Study on nephrotoxicity in rats receiving cis-diammine-1,1-cyclobutane dicarboxylate platinum II--special reference to morphological changes].
    Kimura S, Nakajima Y, Hasegawa S, Tazaki H.
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):517-25. PubMed ID: 2664296
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
    Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR.
    Cancer Res; 1984 Apr; 44(4):1693-7. PubMed ID: 6367971
    [Abstract] [Full Text] [Related]

  • 4. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D, Toubeau G, Laurent G, Tulkens PM, Heuson-Stiennon JA.
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T, Ueda T, Uozumi J, Mihara Y, Kumazawa J.
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [Abstract] [Full Text] [Related]

  • 6. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
    Siddik ZH, Newell DR, Boxall FE, Harrap KR.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1925-32. PubMed ID: 3297068
    [Abstract] [Full Text] [Related]

  • 7. Effect of oxoplatinum and CBDCA on renal functions in rats.
    Láznícková A, Semecký V, Láznícek M, Zubr V, Koksál J, Kvĕtina J.
    Neoplasma; 1989 Jun 15; 36(2):161-9. PubMed ID: 2654665
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of carboplatin.
    van der Vijgh WJ.
    Clin Pharmacokinet; 1991 Oct 15; 21(4):242-61. PubMed ID: 1760899
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
    Egorin MJ, Van Echo DA, Tipping SJ, Olman EA, Whitacre MY, Thompson BW, Aisner J.
    Cancer Res; 1984 Nov 15; 44(11):5432-8. PubMed ID: 6386150
    [Abstract] [Full Text] [Related]

  • 10. Comparative distribution and excretion of carboplatin and cisplatin in mice.
    Siddik ZH, Jones M, Boxall FE, Harrap KR.
    Cancer Chemother Pharmacol; 1988 Nov 15; 21(1):19-24. PubMed ID: 3277732
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Nov 15; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 12. Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in rodent tissue sections.
    Terheggen PM, Floot BG, Scherer E, Begg AC, Fichtinger-Schepman AM, den Engelse L.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6719-25. PubMed ID: 3315190
    [Abstract] [Full Text] [Related]

  • 13. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H.
    J Pharm Pharmacol; 2008 Mar 15; 60(3):317-22. PubMed ID: 18284811
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results.
    Li S, Huang H, Liao H, Zhan J, Guo Y, Zou BY, Jiang WQ, Guan ZZ, Yang XQ.
    Int J Clin Pharmacol Ther; 2013 Feb 15; 51(2):96-105. PubMed ID: 23127487
    [Abstract] [Full Text] [Related]

  • 15. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
    Wolfgang GH, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG.
    Fundam Appl Toxicol; 1994 Jan 15; 22(1):73-9. PubMed ID: 8125216
    [Abstract] [Full Text] [Related]

  • 16. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patients.
    Sharma H, Thatcher N, Baer J, Zaki A, Smith A, McAucliffe CA, Crowther D, Owens S, Fox BW.
    Cancer Chemother Pharmacol; 1983 Jan 15; 11(1):5-7. PubMed ID: 6349844
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA) in humans].
    Zucca E, Cattaneo MT, Cavalli F, Guaitani A, Filipazzi V, Bartosek I.
    G Ital Chemioter; 1985 Jan 15; 32(1):25-8. PubMed ID: 3913618
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
    Sasaki Y, Tamura T, Eguchi K, Shinkai T, Fujiwara Y, Fukuda M, Ohe Y, Bungo M, Horichi N, Niimi S.
    Cancer Chemother Pharmacol; 1989 Jan 15; 23(4):243-6. PubMed ID: 2647312
    [Abstract] [Full Text] [Related]

  • 19. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 15; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats.
    Láznícková A, Láznícek M, Kvĕtina J, Drobník J.
    Cancer Chemother Pharmacol; 1986 Nov 15; 17(2):133-6. PubMed ID: 3521926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.